PIK3CA and pemphigus foliaceus: PI3K/AKT kinase inhibitors are confirmed to inhibit the replication of MERS (Kindrachuk, et al., 2015), and the inhibition of PI3K/AKT signaling pathway contributes to alleviating PF (Fang et al., 2020).